A phase 2 and biomarker study of cabozantinib in patients with advanced cholangiocarcinoma.
卡博替尼治疗晚期胆管癌患者的 2 期临床试验及生物标志物研究
期刊:Cancer
影响因子:5.1
doi:10.1002/cncr.30571
Goyal Lipika, Zheng Hui, Yurgelun Matthew B, Abrams Thomas A, Allen Jill N, Cleary James M, Knowles Michelle, Regan Eileen, Reardon Amanda, Khachatryan Anna, Jain Rakesh K, Nardi Valentina, Borger Darrell R, Duda Dan G, Zhu Andrew X